Who makes Xcell Amnio Matrix?

Xcell Amnio Matrix is developed by New Horizon Medical Solutions.

What development phase is Xcell Amnio Matrix in?

Xcell Amnio Matrix is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Xcell Amnio Matrix

New Horizon Medical Solutions · Phase 1 active Biologic

At a glance

Generic name	Xcell Amnio Matrix
Sponsor	New Horizon Medical Solutions
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Xcell Amnio Matrix CI brief — competitive landscape report
Xcell Amnio Matrix updates RSS · CI watch RSS
New Horizon Medical Solutions portfolio CI